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Conversion of xanthine dehydrogenase to xanthine oxidase as a
possible marker for hypoxia in tumours and normal tissues
R.F. Anderson, K.B. Patel, K. Reghebi & S.A. Hill
Cancer Research Campaign Gray Laboratory, PO Box 100, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, UK.
Summary The enzyme activities of endogenous xanthine dehydrogenase (XDH) and xanthine oxidase (XO)
have been measured in 10 different types of mouse tumour and seven normal tissues. The conversion of XDH
to XO has been observed in two tumour types upon the prolonged clamping off of the blood supply to the
tumours. It is proposed that a similar conversion might also occur naturally in chronically hypoxic cells and
that the ratio of the XO activity to the combined XO+XDH activities (% XO activity) could well serve as a
marker for tissue hypoxia. A qualitative relationship exists between the % XO activity and literature values of
the hypoxic fraction for some tumours measured by radiobiological assays. The influence of tumour size
(about 0.2-1.8g) on % XO activity is presented for all 10 tumours as well as % XO activity determinations
for four of the normal tissues.
The rationale for trying to manipulate oxygen levels in
tumours and the administration of hypoxic-cell radio-
sensitisers in clinical trials presupposes that the selected
tumours contain significant numbers of radioresistant but
viable hypoxic cells (Thomlinson & Gray, 1955). There may
well be a large variability between patients and factors such
as size and growth rate of the tumour might influence the
size of a possible hypoxic fraction. Direct evidence for the
existence of hypoxic regions in animal tumours (Garrecht &
Chapman, 1983; Horowitz et al., 1983) and two human
tumour types (Urtasun et al., 1986) has been obtained by the
binding of administered radiolabelled misonidazole. There is
strong radiobiological evidence that hypoxia exists in a range
of animal tumours but estimations of their hypoxic fraction
often vary widely with the assay method employed (Moulder
& Rockwell, 1984).
We now report a possible direct method of measuring the
hypoxic fraction of tumours, which we have applied to 10
animal tumours, by measuring endogenous enzyme activities.
The method utilises the conversion of endogenous xanthine
dehydrogenase (XDH) to xanthine oxidase (XO). It is known
from the study of rat liver extracts that it is possible to
convert XDH into XO irreversibly by proteolysis, or re-
versibly by treatment with reagents for thiol groups (Della
Corte & Stirpe, 1972). That XDH and not XO was present
in rat organs but that some conversion could take place
during extraction, was also concluded from these early
studies (Giulia Batteli et al., 1972). The proteolytic conver-
sion of XDH to XO under ischemic conditions (Roy &
McCord, 1982) and the concurrent degradation of ATP to
hypoxanthine, a substrate for XDH and XO, have been
proposed as prerequisites for the occurrence of tissue
damage via the production of oxygen free radicals upon
subsequent reperfusion with oxygen (Granger et al., 1981).
There is currently much medical interest in this mechanism
for reperfusion injury (see review by Bulkley, 1987). Our
proposal is that such a conversion of XDH to XO may also
occur in regions of tumours which pass from an oxic state to
a chronically hypoxic state. Certain normal tissues were also
investigated for comparison with the tumours.
Materials and methods
Ten different mouse tumours and seven normal tissues were
used in this study. A description of the tumours, all of which
arose spontaneously and have been maintained by serial
passage, is presented in Table I. Tumours were implanted
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into 12-16-week-old CBA/Gy f TO or WHT/Gy f TO mice
by injection of a crude tumour cell suspension sub-
cutaneously on to the rear dorsum. Tumours were selected at
sizes ranging from about 5 to 13.5mm mean diameter
(0.2-1.8g) and excised immediately after killing the mice by
neck luxation. Tumour samples (and normal tissues) were
placed in vials containing previously ice-cooled buffer solu-
tion and maintained at 0-4°C before and during extraction
of the enzymes. The buffer solution consisted of potassium
phosphate 0.05M, pH7.4), sucrose (0.25M), sodium salicylate
(1 mM) and EDTA (0.3mM).
Clamping procedure
Complete vascular occlusion was achieved by placing a metal
clamp tightly across the base of the tumour. The tumour and
overlying skin were clamped off from the underlying muscle
and surrounding skin without compressing the tumour itself.
Previous studies with tracer methods showed that only
0.01% of an intravascular marker enters the tumour during
30min of clamping (Denekamp et al., 1983). Individual
tumours were clamped for periods of 2-24h and the mice
held either at room temperature (about 21°C) or at 37°C in
a warm room.
Extraction of enzymes
The enzymes were extracted from the tissues using a method
similar to that described in the literature (Ikegami &
Nishino, 1986). Weighed tissue (about 0.5g) was washed in
the ice-cooled buffer followed by homogenisation in 2.5ml
of the same buffer which contained 2mgml-1 soybean
trypsin inhibitor (Sigma Chemical Co.), to reduce any
proteolytic conversion of XDH to XO initiated upon cell
rupture. However, this treatment was ineffective for some
normal tissues due to high protease activity and/or possible
thiol oxidation. Homogenisation of all tissues, except SaS
tumours, was achieved with the aid of a loose-fitting Teflon-
glass homogeniser. Care was taken to maintain the tempera-
ture at 0-4°C during two slow passes of the rapidly rotating
pestle. The SaS tumours could not be homogenised in this
way and were subjected to sonication by a Polytron PT-10
(Kinematica GmbH, Switzerland) using a 5PTS-10S aggre-
gate for 15s at setting 6. The homogenates were centrifuged
at 120,000g for 60min at 0-3°C and the supernatant solu-
tion placed on an ice bath.
Assay method
XDH and XO activities in the supernatant were measured
immediately by following the formation of uric acid from
xanthine at 295nm. The assay was carried out similarly to
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Table I Tumour characteristics
Vol. doubling time (days)
Tumour Mouse Tumour Radiobiological hypoxic
designation strain type Histologya Now At year of exptsb fraction (95% c.l.)c Assayd
CaRh WHT carcinoma p. diff. 8.0 12 (1976-8) 30 (14-62) CT/GD-T
12 (4.3-30) CT/GD-D
CaNT CBA carcinoma mod. diff. 3.0 2.8 (1973-4) 38 (26-55) CT/GD-T
13 (5.5-28) CT/GD-D
CaWW CBA carcinoma mod. diff. 1.5 n.d.
CaMT WHT carcinoma undiff., anapl. 2.0 1.0 (1976) 6.5 (4.1-10) PSC
>51 CT/CD
SaS CBA sarcoma p. diff. 10.0 12.4 (1975-6) 0.5 (0-5.5) CT/GD-D
SaHM CBA sarcoma anapl. 6.0 n.d.
SaNeO WHT sarcoma p. diff. 4.0 n.d.
SaFA WHT sarcoma p. diff., anapl. 4.0 2.7 (1974-5) 81 (25-100) CT/GD-D
95 (18-100) CT/GD-T
WHFib WHT sarcoma undiff., anapl. 3.5 4-5 (1977) 76 (59-98) PSC
SaF CBA sarcoma anapl. 2.1 1.2 (1975) 69 (42-100) PSC
<10 CT/GD-T
ap, poorly; mod., moderately; diff., differentiated; undiff., undifferentiated; anapl., anaplastic. bRadiobiological experiment to determine the
hypoxic fraction of the tumours. CData from the review of Moulder & Rockwell (1984), c.l., confidence limits. dCT/GD, clamped tumour
growth delay method; -T, time for specific growth delay; -D, dose for specific growth delay; PSC, paired survival curve method; CT/CD,
clamped tumour control dose method; n.d., not determined.
that described in the literature (Ikegami & Nishino, 1986)
using paired samples of the supernatant (100-250 M1) with or
without added NAD+ (0.5mM) in potassium phosphate
buffer (50mM, pH7.8) containing EDTA (0.3mM) and xan-
thine (0.25mM) in a spectrophotometer cell of 2.5ml reac-
tion volume thermostated at 25°C. Changes in optical
density were recorded every 30s using a Pye Unicam SP8-
200 spectrophotometer and the initial slopes of the lines
drawn tangentially to the change in optical density with time
were used to determine the initial rates of uric acid produc-
tion. Oxygen present in the aerated reaction volume acted as
the electron acceptor for XO and added NAD+ acted as the
electron acceptor for XDH. The concentrations of added
xanthine and NAD+ were in excess of the concentration of
the enzymes present in each assay (i.e. initial rates of uric
acid production were not affected by the addition of higher
concentrations of xanthine or NAD+). The initial rates of
uric acid production were proportional to the volume of
added supernatant. The total enzymatic activity (XO+XDH)
was measured in aerobic solution in the presence of NAD+
and the XO activity measured in the absence of NAD+. (In
some measurements a short-lived initial fast activity (1-
2min) in the absence of added NAD+ was associated with a
small amount of endogenous NAD+, known to be present in
normal tissue such as liver (Kalhorn et al., 1985) and this
activity was separated out to give the true XO activity). The
XO activity (the possible marker for tissue hypoxia) as a
percentage of the total activity (XO+XDH) was then
calculated.
The protein content of the supernatant was determined by
a modified Lowry method using a commercial kit (Sigma,
no. P5656).
Results
The measured combined activities of XO and XDH in the
tissues studied are presented in Table II. Qualitatively the
enzyme activities for each tissue show a similar relationship
when expressed per 1 g tissue or 1 mg protein. The tumour
data are presented as the average enzyme activity (with
standard errors) of all the individual tumours studied irres-
pective of tumour size. Large errors may indicate differences
in enzyme levels with respect to tumour size and also sample
to sample variations in the efficiency of enzyme extraction.
There are no correlations between the enzyme levels and the
histology or growth rates of the tumours. The slow growing
carcinoma CaRh, for example, has a similar enzyme level to
the faster growing sarcoma SaFA, while the slow growing
SaS and the anaplastic SaHM differ maximally in enzyme
levels. Relative variations in the combined activity of XO
and XDH present in different normal tisues of the mouse are
similar to those known for the rat (Prajda et al., 1976) and
span the range of enzyme activities seen for the tumours
(Table II).
The influence of tumour size on the relative activity of XO
to that of XO+XDH (% XO activity) was studied for both
carcinomas (Figure 1) and sarcoma tumours (Figure 2). The
tumours CaNT, CaWW, SaS and SaNeO display a clear
dependence in %XO activity on tumour size, expressed as
tumour weight. Only the CaNT tumour clearly passes
through a maximum value within the range of tumour size
studied while the SaS tumour reaches a plateau value. The
%XO activity of the tumours at 0.4g, estimated from
Figures 1 and 2, are displayed in Table II. This tumour
weight corresponds to the average treatment size in radiobio-
logical experiments (6-8mm) where the hypoxic fraction of
certain tumours has been measured (Table I).
The changes in % XO activity upon clamping the tumours
CaRh and CaNT for varying lengths of time are displayed in
Figure 3. In both cases the %XO activity increases with
clamping time; the tumours in animals held at 37°C reach
100% XO activity within 12-24h. The tumours in animals
held at room temperature reached 80% XO activity in about
24h. (Displacement of the control values for CaNT is
because larger tumours were used in the room temperature
experiments than at 37°C.) The combined XO+XDH activi-
ties fell during the time of clamping (Figure 4). This is
consistent with the destruction of the enzymes in the necrotic
volume which would be expected to increase during the time
of clamping. Many parameters of the tumours would be
expected to be altered upon the crude clamping off of the
tumours, such as the lowering of the pH and destruction of
glucose (through glycolysis) as well as the enhancement of
metabolic products formed in hypoxia.
Discussion
A strict comparison between %XO activity and the radio-
biological hypoxic fraction of the tumours cannot be made
from this study. This is because the hypoxic fractions of the
tumours used in the present study have not been measured
for several years and could conceivably have changed with
time. Repeated transplantation can cause many changes in
tumour characteristics such as growth rate, histology and
degree of hypoxia. Despite frequently returning to frozen
stocks, we have measured some changes in tumour growth,ENZYME MARKER FOR TUMOUR HYPOXIA
Table II Enzyme activity levels
No. of XO activity Total XO+XDH activity %XO activity'
Tumour samples (umolh- 1g-1) #tmolh-1g-1 molh-1mg protein-1 (for wt=0.4g)b
CaRH 8 1.98 +0.44 7.63+ 1.09 0.280+0.051 26+4c
CaNT 13 0.33+0.14 1.18+0.29 0.041 +0.015 38
CaWW 7 1.01+0.17 2.43+0.24 0.098+0.013 34
CaMT 11 0.30+0.23 1.06+0.70 0.070+0.028 (22)d
SaS 9 0.13+0.08 0.53+0.16 0.021+0.004 12
SaHM 5 2.44+0.41 9.37+2.27 0.397+0.098 24
SaNeO 6 2.65+0.78 7.50+ 1.04 0.230+0.039 25
SaFA 11 3.32+0.61 7.57+0.77 0.253+0.055 52
WHFib 7 1.03+0.32 3.29+0.61 0.104+0.051 31 +5c
SaF 6 0.44+0.09 1.26+0.35 0.042+0.012 42
Normal tissue
Jejunum 2 n.d. 9.75+1.90 0.492+0.110 n.d.
Liver 14 1.10+0.34 5.90+ 1.29 0.108+0.024 17+3
Lung 2 n.d. 2.45+0.30 0.077+0.011 n.d.
Heart 9 n.d. 1.63+0.68 0.049+0.014 n.d.
Kidney 2 n.d. 1.34+0.18 0.038+0.011 <10
Spleen 2 0 0.62+0.32 0.012+0.003 0
Brain 1 0 0.10 0.005 0
aEstimates (approx. 10% error) from Figures 1 and 2. bTumour weight corresponds to 6-8 mm treatment size.
CAverage value independent of tumour size. d 10% error in estimate; n.d., unable to be determined due to high
protease activity and/or possible thiol oxidation.
as detailed in Table I. Growth rate acceleration is a common
observation but the reverse trend is more unusual (Steel,
1977). The slowing of growth suggested here could result
from inadvertent selection of a slow growing variant, but
may simply reflect the small numbers of animals from which
the recent values were obtained (typically 4 or 5), together
with differences in the measuring technique of individual
investigators over the years.
Even if the tumours have remained unchanged, it is well
known that different radiobiological assays lead in many
cases to different estimates of the hypoxic fraction (Moulder
& Rockwell, 1984). This is illustrated for the SaF and CaNT
in Table I. The aim here has therefore been to compare
qualitatively the trends in %XO activity and hypoxic frac-
tion. Most radiobiological work has been done using
tumours of about 6-8mm mean diameter (about 0.4g) and
the %XO activity of these sized tumours are presented in
Table II for comparison. We see the trend of a low % XO
for SaS, medium activity for CaRh and CaNT and high
activity for SaFA which is the same order of their radiobio-
logical hypoxic fractions.
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The faster conversion of XDH to XO at 37°C compared
to room temperature (Figure 3) is consistent with a tempera-
ture dependence of an enzymic reaction such as proteolysis.
The timescale for the conversion of XDH to XO in clamped
tumours is far longer than the induction of radiobiological
hypoxia in tumours, which occurs upon clamping for about
5min (Denekamp & Harris, 1975), and in epidermal cells
which are radiobiologically hypoxic within about 30s of
mice breathing nitrogen (Denekamp et al., 1974). This
observation suggests that the enzyme conversion takes place
in chronically hypoxic cells and not in acutely hypoxic cells
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Figure Dependence of relative enzyme activity on the weight
of mouse carcinomas. Lines are fitted by eye.
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Figure 2 Dependence of relative enzyme activity on the weight
of mouse sarcoma tumours. Lines are fitted by eye.
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Figure 3 Dependence of relative enzyme activity on the time of
clamping the tumours. a, CaRh; b, CaNT. Open symbols are for
animals held at room temperature, filled symbols are for animals
held at an ambient temperature of 37°C.
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Figure 4 Dependence of enzyme activity levels (XO+XDH) on
the time that the tumours are clamped. Open symbols are for
animals held at room temperature, filled symbols for animals
held at an ambient temperature of 37°C.
which have been hypoxic only for a short time. Both
chronically and acutely hypoxic cells are known to be more
resistant to irradiation than oxic cells, and could present a
clinical problem if a proportion of them survive treatment
and initiate tumour regrowth. The acutely hypoxic cells
resulting from temporary or cyclic vascular occlusion may be
of less clinical importance than chronically hypoxic cells as
they are likely to be oxic during several of the treatments in
multifraction radiotherapy. In situ radiobiological assays,
such as regrowth delay, measure the combined chronic and
acute hypoxic fractions of tumours so if acute hypoxia is a
significantly large proportion of the total hypoxia (Brown,
1979; Chaplin et al., 1987) then the % XO activity could
underestimate the hypoxic fraction.
The dependence of necrotic fraction on tumour size has
been published for CaNT and SaF (Smith et al., 1988) and is
reproduced in Figure 5 for comparison with the % XO
activity measurements. The increase in necrotic fraction of
CaNT parallels the increase in % XO activity up to about
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Figure 5 Dependence of the % necrosis on tumour weight for
CaNT (a) and SaF (b). Data from Smith et al. (1988). Broken
lines are the %XO activity measurement for each tumour
reproduced from Figures I and 2.
0.7g tumour weight during which an approximate pro-
portionality of 2 to 1 between chronically hypoxic and
necrotic fractions can be deduced. This proportionality
breaks down in larger tumours: when the necrotic fraction
rises above 25% the chronically hypoxic fraction falls. This
may well be the point at which not all regions of the tumour
can be equally served by the growing vasculature. As the
proportion of necrosis increases neoangiogenesis may result
in the viable tumour tissue becoming better vascularised. A
decrease in the hypoxic fraction would follow. Since tumours
differ in their angiogenic properties this transition point
might be expected to be tumour dependent. The chronically
hypoxic fraction of the SaF tumour reaches a maximum at a
smaller tumour size than for CaNT. The fact that in the
CaNT tumour a maximum followed by a decrease in % XO
activity is observed and the %XO activity of the SaF
tumour does not continue to rise while the necrotic volume
steadily rises, implies that the marker enzymes are destroyed
in the necrotic regions. This conclusion is supported by the
direct measurements of the fall in the combined activities of
XO and XDH upon prolonged clamping (Figure 4) in which
the necrotic volume would be expected to rise.
Early studies concluded that probably only XDH is
present in rat organs (Giulia Battelli et al., 1972) but is
partially converted to XO as a result of the oxidation of
thiol groups as well as by proteolytic enzymes in some
tissues during extraction. More recent studies on rat liver
have shown that XO activity in fresh extracts is 17% of the
total XO+XDH activities (Ikegami et al., 1986) which is the
same figure as we have found for mouse liver (Table II).
That mouse liver exists at a reduced oxygen tension, com-
pared to other normal tissues, was concluded from the in
vivo binding of 14C-misonidazole to liver (Os-Corby &
Chapman, 1986). The level of 14C activity retained in the
liver was compared to that retained in the EMT-6 tumour
(Garrecht et al., 1983). A Do of 3.3Gy has been reported for
the radiosensitivity of mouse hepatocyte clonogens (Fisher et
al., 1988), which is high compared to a range of mammalian
cell lines (Alper, 1979) and might indicate the presence of a
subpopulation of hypoxic cells.
In conclusion evidence from this study indicates that the
parameter % XO activity of XO+XDH activities might well
be useful in determining possible hypoxic fractions of tissues.
The whole range of measurements from zero hypoxic frac-
tion, observed for certain normal tissues, to 100% hypoxic
fraction induced upon clamping off of tumours (albeit on a
longer timescale than the induction of radiobiological
hypoxia) has been demonstrated. Validation of the method
by concurrent radiobiology experiments and extension of the
method to human tumours is clearly warranted and is in
hand.
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